期刊
EUROPEAN JOURNAL OF PHARMACOLOGY
卷 616, 期 1-3, 页码 256-264出版社
ELSEVIER
DOI: 10.1016/j.ejphar.2009.06.027
关键词
Renal ischemia-reperfusion injury; Glycine derivative; Antioxidant moiety; Anti-inflammatory agent
资金
- NASA-MSGC [R85198]
- Research Excellence Fund [R01121]
- Natural Science Foundation of HeBei, China [062761266]
- Administration of Traditional Chinese Medicine of HeBei Province [2007134]
Renal ischemia/reperfusion is a common cause of acute renal failure. Glycine is an effective anti-inflammatory, cytoprotective agent and is reported to have a beneficial effect against ischemia/reperfusion injury in various organs. Previous research notes that free radicals and inflammatory leukocytes both play important roles in the pathogenesis of renal ischemia/reperfusion injury. To develop new therapeutic agents against renal ischemia/reperfusion injury, we sought to link an antioxidant moiety (nitronyl nitroxide) to glycine in the hope that the resulting glycine-nitronyl nitroxide conjugate (GNN) would provide a synergetic protection against renal ischemia/reperfusion injury. In this manuscript, we report the synthesis and biological evaluation of the GNN conjugate. The biological activity of the GNN conjugate was evaluated in an in vivo rat model of renal ischemia/reperfusion induced injury and oxidative change. Since the GNN conjugate markedly reduced elevated levels of tissue lipid peroxidation and attenuated renal dysfunction in rats subjected to renal ischemia/reperfusion, it might be possible to develop the GNN conjugate into a potential therapeutic agent against renal ischemia/reperfusion injury. Published by Elsevier B.V.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据